ZA995872B - Streptomyces avermitilis regulatory genes for increased avermectin production. - Google Patents

Streptomyces avermitilis regulatory genes for increased avermectin production.

Info

Publication number
ZA995872B
ZA995872B ZA9905872A ZA995872A ZA995872B ZA 995872 B ZA995872 B ZA 995872B ZA 9905872 A ZA9905872 A ZA 9905872A ZA 995872 A ZA995872 A ZA 995872A ZA 995872 B ZA995872 B ZA 995872B
Authority
ZA
South Africa
Prior art keywords
increased
regulatory genes
streptomyces avermitilis
avermectin production
avermectin
Prior art date
Application number
ZA9905872A
Other languages
English (en)
Inventor
Kim Jonelle Stutzman-Engwall
Brenda Sue Price
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of ZA995872B publication Critical patent/ZA995872B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • C12P19/623—Avermectin; Milbemycin; Ivermectin; C-076
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/36—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Actinomyces; from Streptomyces (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C12N15/76—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Actinomyces; for Streptomyces

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA9905872A 1998-09-14 1999-09-13 Streptomyces avermitilis regulatory genes for increased avermectin production. ZA995872B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US10013498P 1998-09-14 1998-09-14

Publications (1)

Publication Number Publication Date
ZA995872B true ZA995872B (en) 2001-03-13

Family

ID=22278261

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9905872A ZA995872B (en) 1998-09-14 1999-09-13 Streptomyces avermitilis regulatory genes for increased avermectin production.

Country Status (17)

Country Link
US (2) US6197591B1 (id)
EP (1) EP0997528A1 (id)
JP (1) JP3595210B2 (id)
KR (1) KR100343357B1 (id)
CN (1) CN1252440A (id)
AR (1) AR021485A1 (id)
AU (1) AU758329B2 (id)
BR (1) BR9904109A (id)
CA (1) CA2281935A1 (id)
HU (1) HUP9903073A3 (id)
ID (1) ID23542A (id)
IL (1) IL131845A0 (id)
IN (1) IN190976B (id)
PL (1) PL335438A1 (id)
RU (1) RU2221042C2 (id)
TR (1) TR199902239A2 (id)
ZA (1) ZA995872B (id)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6720415B2 (en) * 1998-12-02 2004-04-13 Princeton University Compositions and methods for regulating bacterial pathogenesis
US7326542B2 (en) * 1998-12-02 2008-02-05 Princeton University Compositions and methods for regulating bacterial pathogenesis
CA2402398A1 (en) * 2000-02-24 2001-08-30 Kyowa Hakko Kogyo Co., Ltd. Process for producing avermectin derivative
US6559176B1 (en) 2000-05-10 2003-05-06 Princeton University Compounds and methods for regulating bacterial growth and pathogenesis
US7630836B2 (en) * 2001-05-30 2009-12-08 The Kitasato Institute Polynucleotides
IL162866A0 (en) * 2002-02-12 2005-11-20 Pfizer Prod Inc Streptomyces a vermitilis gene directing the ratioof b2:b1 avermectins
US7326782B2 (en) * 2003-08-21 2008-02-05 Wisconsin Alumni Research Foundation Metabolic engineering of viomycin biosynthesis
US7645600B2 (en) * 2004-07-23 2010-01-12 Shin-Etsu Chemical Co., Ltd. Compositions and methods for enhanced bacterial exopolysaccharide production
KR100564156B1 (ko) * 2004-08-23 2006-03-24 주식회사 진켐 스트렙토마이세스 푸세티우스 유래 전사활성체 및 그 유전자
JP2006296419A (ja) * 2005-03-04 2006-11-02 Hiroshima Univ 遺伝子破壊による抗生物質産生微生物の生産方法およびこれを用いて得られる抗生物質産生微生物、並びに抗生物質代謝中間体の生産方法
KR20140001229A (ko) * 2007-03-30 2014-01-06 아보트 러보러터리즈 숙주 세포에서 재조합 단백질의 발현을 증강시키기 위한 재조합 발현 벡터 요소(ｒＥＶＥ)

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4362816A (en) 1980-11-13 1982-12-07 The Upjohn Company Hybrid plasmid and process of making same
US4898828A (en) 1985-08-07 1990-02-06 Eli Lilly And Company Ultrahigh copy number streptomycetes plasmids
US5242809A (en) 1986-02-28 1993-09-07 Smithkline Beecham Corporation Gal operon of streptomyces
US5238848A (en) 1987-01-23 1993-08-24 Pfizer Inc Cultures for production of avermectins
US5525506A (en) 1987-01-23 1996-06-11 Pfizer Inc. Process for production of avermectins and cultures therefor
US5234831A (en) 1987-01-23 1993-08-10 Pfizer Inc Cultures for production of B avermectins
ES2054822T3 (es) 1987-10-23 1994-08-16 Pfizer Procedimiento para la produccion de agliconas de avermectinas y sus cultivos.
US5240850A (en) 1987-10-23 1993-08-31 Pfizer Inc. Cultures for production of avermectin aglycones
DE3825615A1 (de) * 1988-07-28 1990-02-01 Behringwerke Ag Antigenkonstrukte von "major histocompatibility complex" klasse i antigenen mit spezifischen traegermolekuelen, ihre herstellung und verwendung
US5264354A (en) 1988-09-30 1993-11-23 Eli Lilly And Company Method for isolating transposable elements from streptomyces
US5252474A (en) 1989-03-31 1993-10-12 Merck & Co., Inc. Cloning genes from Streptomyces avermitilis for avermectin biosynthesis and the methods for their use
EP0391594B1 (en) 1989-03-31 1995-10-18 Merck & Co. Inc. Cloning genes from streptomyces avermitilis for avermectin biosynthesis and the methods for their use
US5122595A (en) 1989-05-19 1992-06-16 Applied Research Systems Ars Holding N.V. SAF polypeptide gene coding therefor, and SAF promoter
US5118617A (en) 1989-05-19 1992-06-02 Applied Research Systems Ars Holding N.V. Saf polypeptide, gene coding therefor, saf promoter and expression methods for expressing foreign dna sequences in streptomyces
BR9407211A (pt) 1993-07-30 1996-09-17 Pfizer Genes codificadores do complexo de desidrogenase de alfa- cetoácidos de cadeia ramificada derivados de streptomyces avermitilis
FI942725A (fi) 1993-12-16 1995-06-17 Pfizer Haaraketjuista alfaketohappodenydrogenaasikompleksia koodaavia geenejä Streptomyces avermitiliksesta
US5474912A (en) 1994-03-03 1995-12-12 Sherman; David H. Method for increasing production of microbial metabolites by genetic engineering
US5876987A (en) 1996-02-07 1999-03-02 Board Of Trustees Operating Michigan State University Method, DNA and bacteria for hyperproduction of an antibiotic due to disruption of an AbsA gene

Also Published As

Publication number Publication date
EP0997528A1 (en) 2000-05-03
BR9904109A (pt) 2000-10-17
JP2000102394A (ja) 2000-04-11
AU758329B2 (en) 2003-03-20
AR021485A1 (es) 2002-07-24
ID23542A (id) 2000-05-04
IN190976B (id) 2003-09-06
US6689611B1 (en) 2004-02-10
CN1252440A (zh) 2000-05-10
AU4757599A (en) 2000-03-23
HU9903073D0 (en) 1999-11-29
RU2221042C2 (ru) 2004-01-10
KR20000023111A (ko) 2000-04-25
HUP9903073A2 (en) 2000-07-28
KR100343357B1 (ko) 2002-07-15
CA2281935A1 (en) 2000-03-14
TR199902239A2 (xx) 2000-04-21
HUP9903073A3 (en) 2005-05-30
IL131845A0 (en) 2001-03-19
JP3595210B2 (ja) 2004-12-02
US6197591B1 (en) 2001-03-06
PL335438A1 (en) 2000-03-27

Similar Documents

Publication Publication Date Title
ZA991837B (en) Biosynthetic genes for spinosyn insecticide production.
ZA985018B (en) 9-oxime erythromycin derivatives.
HK1034978A1 (en) Adenosine derivatives.
ZA200107408B (en) Camptothecin derivatives having antitumor activity.
ZA200103289B (en) Novel macrolide antibiotics.
AU5096600A (en) Lottery system
AU4139799A (en) Improvements in macrolide production
AU2001278694A1 (en) Avermectin derivatives
ZA200107346B (en) Erythromycin derivatives.
ZA995872B (en) Streptomyces avermitilis regulatory genes for increased avermectin production.
AU5705000A (en) Process for selective lactonization
HK1046536A1 (en) Streptomyces avermitilis gene directing the ratio of b2:b1 avermectins.
ZA991138B (en) Streptomyces avermitilis gene directing the ratio of B2: B1 avermectins.
AU2658899A (en) Process for making clarithromycin
HK1027110A1 (en) Production of avermectin compounds.
HK1046710A1 (en) Streptomyces avermitilis gene directing the rationof B2:B1 avermectins.
HK1045698A1 (zh) 阿維菌素衍生物
EP1206477A4 (en) CLONING OF THE STREPTOMYCES AVERMITILIS GENES FOR THE GLYCOSYLATION OF AVERMECTIN AGLYCONES
EP1160325A4 (en) AVERMECTIN AGLYCON SYNTHASE GENE
ZA200405345B (en) Streptomyces avermitilis gene directing the ratio of B2:B1 avermectins.
AU3883299A (en) Cancer prevention by selective delivery methods
AU3274099A (en) Process for producing avermectin b1 derivatives
AU2001277712A1 (en) Avermectin derivatives
GB9817031D0 (en) Antibiotic genes
AU2003204618A1 (en) Novel Erythromycin Derivatives